The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer
Open accessAbstract
It is well recognized that hypoxia-inducible factor 1 alpha (HIF-1α) is involved in cancer metastasis, chemotherapy and poor prognosis. We previously found that deferoxamine, a hypoxia-mimetic agent, induces epithelial-mesenchymal transition (EMT) in colorectal cancer. Therefore, here we explored a new molecular mechanism for HIF-1α contributing to EMT and cancer metastasis through binding to ZEB1. In this study, we showed that overexpression of HIF-1α with adenovirus infection promoted EMT, cell invasion and migration in vitro and in vivo. On a molecular level, HIF-1α directly binding to the proximal promoter of ZEB1 via hypoxia response element (HRE) sites thus increasing the transactivity and expression of ZEB1. In addition, inhibition of ZEB1 was able to abrogate the HIF-1α-induced EMT and cell invasion. HIF-1α expression was highly correlated with the expression of ZEB1 in normal colorectal epithelium, primary and metastatic CRC tissues. Interestingly, both HIF-1α and ZEB1 were positively associated with Vimentin, an important mesenchymal marker of EMT, whereas negatively associated with E-cadherin expression. These findings suggest that HIF-1α enhances EMT and cancer metastasis by binding to ZEB1 promoter in CRC. HIF-1α and ZEB1 are both widely considered as tumor-initiating factors, but our results demonstrate that ZEB1 is a direct downstream of HIF-1α, suggesting a novel molecular mechanism for HIF-1α-inducing EMT and cancer metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have demonstrated that HIF has a direct regulatory effect on EMT‐related proteins, such as zinc finger E‐box binding homeobox 1, Snail and Twist.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [87]
In the citing paper
“A direct role for HIF in the regulation of key EMT transcription factors such as ZEB1, Snail, and Twist has been demonstrated through the identification of functional hypoxia response elements (HREs) within the regulatory elements of these genes”
From Hypoxic control of metastasis (2016) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 1×
“homeobox 1 (ZEB1), ZEB2, and/or E47, which can bind to E-cadherin promoter and inhibit its transcription activity and expression [2].”
BackgroundDirect regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Self-citationHypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30487 · Cited by 976
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208429 · Cited by 808
HIF-1 as a target for drug development
Giaccia, A., Siim, B. G., & Johnson, R. S. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1199 · Cited by 631
The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A. W., Bauer, K., Sultan, A., Hlubek, F., Jung, A., Strand, D. J., Eger, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5682 · Cited by 558
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 529
Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J. H., & Semenza, G. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3719 · Cited by 415
Tsai, C., Chen, Y.-J., Yew, T., Chen, L., Wang, J., Chiu, C., & Hung, S. (2010) · Blood · doi:10.1182/blood-2010-05-287508 · Cited by 389
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 264
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Antitumor effects of circ‐EPHB4 in hepatocellular carcinoma via inhibition of HIF‐1α
Tan, Y.-H., Du, B., Zhan, Y., Wang, K., Wang, X., Chen, B., Wei, X., & Xiao, J. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22976 · Cited by 36
Severe neonatal anemia increases intestinal permeability by disrupting epithelial adherens junctions
MohanKumar, K., Namachivayam, K., Sivakumar, N., Alves, N. G., Sidhaye, V. K., Das, J. K., Chung, Y., Breslin, J. W., & Maheshwari, A. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00324.2019 · Cited by 36
Kim, I., Lee, J. H., Kim, S., Hwang, H., Kim, T., & Cho, E. (2018) · Cancer Science · doi:10.1111/cas.13791 · Cited by 36
Zhou, F., Du, C., Xu, D., Lu, J., Zhou, L., Wu, C., Wu, B., & Huang, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11188 · Cited by 35
RetractedMi, Y., Mu, L., Huang, K., Hu, Y., Yan, C., Zhao, H., Ma, C., Li, X., Tao, D., & Qin, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02797-z · Cited by 38
Ray, U., Roy, S. S., & Chowdhury, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000458744 · Cited by 34
Marín‐Ramos, N. I., Jhaveri, N., Thein, T. Z., Fayngor, R. A., Chen, T. C., & Hofman, F. M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.034 · Cited by 34
Abdullah, N. A., Hashim, N. F. M., Ammar, A., & Zakuan, N. M. (2021) · Molecules · doi:10.3390/molecules26040775 · Cited by 34
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
Gaete, D., Rodriguez, D., Watts, D., Sormendi, S., Chavakis, T., & Wielockx, B. (2021) · Cancers · doi:10.3390/cancers13050988 · Cited by 35
Identification, functional insights and therapeutic targeting of EMT tumour states
Dong, A., & Blanpain, C. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00873-0 · Cited by 41
Zhang, W., Wu, X., Hu, L., Ma, Y., Xiu, Z., Huang, B., Feng, Y., & Tang, X. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14813880882288 · Cited by 33
Self-citationRichter, K., Paakkola, T., Mennerich, D., Kubaichuk, K. I., Konzack, A., Ali-Kippari, H., Kozlova, N., Koivunen, P., Haapasaari, K., Jukkola‐Vuorinen, A., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0452 · Cited by 34
Fu, Y., Zhang, Y., Cui, J., Yang, G., Peng, S., Mi, W., Yin, X., Yu, Y., Jiang, J., Liu, Q., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0518-0 · Cited by 33
Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2.
Zhu, P., Mao, M., Liu, Z. G., Li, T., & Yan, B. C. (2017) · Europe PMC (PubMed Central) · Cited by 32
Neddylation: A Versatile Pathway Takes on Chronic Liver Diseases
Yao, J., Liang, X. Y., Liu, Y., & Zheng, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.586881 · Cited by 33
Transcriptome Landscape of Epithelial to Mesenchymal Transition of Human Stem Cell–Derived RPE
Sripathi, S. R., Hu, M.-W., Liu, M. M., Wan, J., Cheng, J., Duan, Y., Mertz, J. L., Wahlin, K. J., Maruotti, J., Berlinicke, C. A., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.4.1 · Cited by 32
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunitiesPreprint
Shen, M., & Kang, Y. (2020) · Genes & Development · doi:10.1101/gad.343251.120 · Cited by 31
GDF15 promotes epithelial-to-mesenchymal transition in colorectal
Zhang, Y., Wang, X., Zhang, M., Zhang, Z., Jiang, L., & Li, L. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1466146 · Cited by 30
Bommi, P. V., Ravindran, S., Raychaudhuri, P., & Bagchi, S. (2018) · Oncotarget · doi:10.18632/oncotarget.26168 · Cited by 29
Zheng, H., Wu, Y., Guo, T., Liu, F., Xu, Y., & Cai, S. (2020) · BioMed Research International · doi:10.1155/2020/5958272 · Cited by 31
Self-citationvan Gisbergen, M. W., Offermans, K., Voets, A. M., Lieuwes, N. G., Biemans, R., Hoffmann, R. F., Dubois, L. J., & Lambin, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00770 · Cited by 30
Spinetti, G., Sangalli, E., Specchia, C., Villa, F., Spinelli, C., Pipolo, R., Carrizzo, A., Greco, S., Voellenkle, C., Vecchione, C., et al. (2017) · Aging · doi:10.18632/aging.101159 · Cited by 29
Hashimoto, M., Uesugi, N., Osakabe, M., Yanagawa, N., Otsuka, K., Kajiwara, Y., Ueno, H., Sasaki, A., & Sugai, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.690816 · Cited by 29
Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 31
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Strippoli, R., Niayesh‐Mehr, R., Adelipour, M., Khosravi, A., Cordani, M., Zarrabi, A., & Allameh, A. (2024) · Cancers · doi:10.3390/cancers16040807 · Cited by 30
Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter
Feng, S., Ding, B., Dai, Z., Yin, H., Ding, Y., Liu, S., Zhang, K., Lin, H. R., Xiao, Z., & Shen, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05085-y · Cited by 32
Self-citationSharma, A., Kansara, S., Mahajan, M., Yadav, B., Garg, M., & Pandey, A. K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166240 · Cited by 27
Hypoxia-Induced Epithelial-Mesenchymal Transition Is Involved in Bleomycin-Induced Lung Fibrosis
Guo, L., Xu, J., Liu, L., Liu, S.-M., & Zhu, R. (2015) · BioMed Research International · doi:10.1155/2015/232791 · Cited by 28
Self-citationNi, Q., Li, M., & Yu, S. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221081219 · Cited by 29
Chen, S., Chen, X., Li, W., Shan, T., Lin, W. R., Ma, J., Cui, X., Yang, W., Cao, G., Li, Y., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8219 · Cited by 26
RetractedElsayed, A. M., Amero, P., Salama, S. A., Abdel‐Aziz, A. H., Lopez‐Berestein, G., & Rodriguez‐Aguayo, C. (2020) · Cancers · doi:10.3390/cancers12092406 · Cited by 25
Role of circular RNAs in colorectal tumor microenvironment
Ashraf, J. V., Nair, V. S., Saleh, R., & Elkord, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111351 · Cited by 26
Tsiampali, J., Neumann, S., Giesen, B., Koch, K., Maciaczyk, D., Janiak, C., Hänggi, D., & Maciaczyk, J. (2020) · Pharmaceuticals · doi:10.3390/ph13110378 · Cited by 26
Peng, X.-F., Yan, J., & Cheng, F. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152853 · Cited by 25
Nahomi, R. B., & Nagaraj, R. H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26877 · Cited by 26
Sugai, T., Uesugi, N., Kitada, Y., Yamada, N., Osakabe, M., Eizuka, M., Sugimoto, R., Fujita, Y., Kawasaki, K., Yamamoto, E., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25646 · Cited by 25
Exosomes as a Nano-Carrier for Chemotherapeutics: A New Era of Oncology
Araldi, R. P., Delvalle, D. A., da Costa, V. R., Alievi, A. L., Teixeira, M. R., Pinto, J. R. D., & Kerkis, I. (2023) · Cells · doi:10.3390/cells12172144 · Cited by 27
Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy
Zhang, M., Zhang, Y., Ding, Y., Huang, J., Yao, J., Xie, Z., Lv, Y., & Zuo, J. (2022) · Cells · doi:10.3390/cells11182811 · Cited by 26
Yeh, C.-C., Luo, J.-L., Phan, N. N., Cheng, Y., Chow, L., Tsai, M., Chuang, E. Y.-Y., & Lai, L. (2018) · RNA Biology · doi:10.1080/15476286.2018.1553480 · Cited by 24
Metabolic dependencies of metastasis-initiating cells in female breast cancer
Young, C. M., Beziaud, L., Dessen, P., Alonso, A. M., Santamaria‐Martínez, A., & Huelsken, J. (2023) · Nature Communications · doi:10.1038/s41467-023-42748-8 · Cited by 26
Zhao, S., Zhou, L., Dicker, D. T., Lev, A., Zhang, S., Ross, E. A., & El‐Deiry, W. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00150-8 · Cited by 22
Malamas, A. S., Jin, E., Gujrati, M. D., & Lu, Z. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00227 · Cited by 22
HINT2 downregulation promotes colorectal carcinoma migration and metastasis
Li, W., Cai, S., Wang, L., Yang, C., Zhou, B., & Wang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14587 · Cited by 22
Jia, Z., Liu, W., Gong, L., & Xiao, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.5581 · Cited by 22
RhoJ promotes hypoxia induced endothelial‐to‐mesenchymal transition by activating WDR5 expression
Liu, L., Chen, J., Sun, L., & Xu, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26505 · Cited by 21
Jiang, Z., Yang, H., Zhang, X., Wang, Z., Rong, R., & Wang, X. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.10.031 · Cited by 21
Li, Y., Huang, T., Fu, Y., Wang, T., Zhao, T., Guo, S. J., Sun, Y., Yang, Y., & Li, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215886 · Cited by 21
Liu, Y., Siles, L., Lu, X., Dean, K. C., Cuatrecasas, M., Postigo, A. A., & Dean, D. C. (2018) · Nature Communications · doi:10.1038/s41467-018-04663-1 · Cited by 21
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma
Astore, S., Baciarello, G., Cerbone, L., & Calabrò, F. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.33 · Cited by 20
The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
Boros, É., & Nagy, I. (2019) · Cells · doi:10.3390/cells8111461 · Cited by 21
He, X., Han, Z., Jiang, W., Huang, F., Ren, C., Wei, Q., & Zhou, N. (2020) · Acta Histochemica · doi:10.1016/j.acthis.2020.151593 · Cited by 20
Jin, Y., Xie, H., Duan, L., Zhao, D., Ding, J.-A., & Jiang, G. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s226078 · Cited by 19
The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis
Șușman, S., Pîrlog, R., Leucuta, D., Mitre, A. O., Padurean, V. A., Melincovici, C. S., Moldovan, I. M., Crişan, D., & Florian, I. Ş. (2019) · Diagnostic Pathology · doi:10.1186/s13000-019-0903-4 · Cited by 18
Carroll, C., Bolland, H. R., Vancauwenberghe, E., Collier, P., Ritchie, A., Clarke, P. A., Grabowska, A. M., Harris, A. L., & McIntyre, A. (2022) · Neoplasia · doi:10.1016/j.neo.2022.01.003 · Cited by 19
Wang, Y., Zhang, Y., Liu, G., Shi-he, W., Jiang, F., & Xie, J. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s96723 · Cited by 19
Chen, B., Fan, Z., Sun, L., Chen, J., Feng, Y., Fan, X., & Xu, Y. (2020) · Oncogenesis · doi:10.1038/s41389-020-00269-9 · Cited by 18
Izzotti, A., Ceccaroli, C., Geretto, M., Ruggieri, F. G., Schenone, S., & Maria, E. D. (2020) · Cancers · doi:10.3390/cancers12061652 · Cited by 19
Farina, A. R., Cappabianca, L. A., Zelli, V., Sebastiano, M., & Mackay, A. R. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.685 · Cited by 19
PPARG expression in colorectal cancer and its association with staging and clinical evolution
Villa, A. L. P., Parra, R. S., Feitosa, M. R., de Camargo, H. P., Machado, V. F., Tirapelli, D. P. D. C., da Rocha, J. J. R., & Féres, O. (2020) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020200070000008 · Cited by 17
Regulation of epithelial‐to‐mesenchymal transition in hypoxia by the HIF‐1α network
Wang, H., Zhang, X., & Wang, W. (2021) · FEBS Letters · doi:10.1002/1873-3468.14258 · Cited by 17
Sirtuins and Hypoxia in EMT Control
Aventaggiato, M., Barreca, F., Sansone, L., Pellegrini, L., Russo, M. A., Cordani, M., & Tafani, M. (2022) · Pharmaceuticals · doi:10.3390/ph15060737 · Cited by 18
Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration
Brockmueller, A., Girisa, S., Motallebi, M., Kunnumakkara, A. B., & Shakibaei, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1203436 · Cited by 16
Upadhyay, P., Ghosh, A., Basu, A., Pranati, P. A., Gupta, P. C. S., Das, S., Sarker, S., Bhattacharjee, M., Bhattacharya, S., Ghosh, S., et al. (2021) · Biomaterials Science · doi:10.1039/d1bm01148k · Cited by 16
Modulating hypoxia inducible factor‐1 by nanomaterials for effective cancer therapy
Sun, Y. H., Zhou, Z., Yang, S., & Yang, H. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1766 · Cited by 16
Qi, Q.-M., Guo, S.-W., & Liu, X.-S. (2019) · Reproductive and Developmental Medicine · doi:10.4103/2096-2924.262390 · Cited by 15
“[28] As a transcription factor, HIF-1α regulates the activities of its downstream genes by binding the HREs in their promoter regions.[29] For example, COX-2 expression is regulated by HIF-1α transcriptional activity.”
BackgroundHypoxia as a regulator of tumor stroma and metastasis
Lee, K. E. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00158.2022 · Cited by 17
Villareal, L., Falcon, D. M., Xie, L., & Xue, X. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02699-3 · Cited by 17
Microbubble-Mediated Cavitation Promotes Apoptosis and Suppresses Invasion in AsPC-1 Cells
Cao, J., Hu, C., Zhou, H., Qiu, F., Chen, J., Zhang, J., & Huang, P. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.10.014 · Cited by 15
Kim, Y., Park, J. B., Fukuda, J., Watanabe, M., & Chun, Y. (2021) · Cancers · doi:10.3390/cancers13030531 · Cited by 15
Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
Galindo-Vega, A., Maldonado, V., Mitre-Aguilar, I. B., & Meléndez-Zajgla, J. (2023) · Cells · doi:10.3390/cells12121560 · Cited by 14
Khalafizadeh, A., Hashemizadegan, S. D., Shokri, F., Bakhshinejad, B., Jabbari, K., Motavaf, M., & Babashah, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18197 · Cited by 15
Chen, D., Wang, H., Bao, Y., & Xie, K. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8502 · Cited by 14
Liu, J., Ni, X., Li, Y., Chen, M., Chen, W., Wu, Y., Chen, B., Wu, Y. R., & Xu, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28849 · Cited by 14
Self-citationHypoxaMIRs: Key Regulators of Hallmarks of Colorectal Cancer
Coronel-Hernández, J., Delgado-Waldo, I., Cantú de León, D., López-Camarillo, C., Jacobo-Herrera, N., Ramos-Payán, R., & Pérez-Plasencia, C. (2022) · Cells · doi:10.3390/cells11121895 · Cited by 13
He, Y., Wang, W. T., Jiang, P., Yang, L., Guo, Q., Xiang, J., Gao, Y., Wang, Y., & Chen, R. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s337014 · Cited by 13
Implementing Curcumin in Translational Oncology Research
Gall‐Tros̆elj, K., Samaržija, I., Tomljanović, M., Kujundžić, R. N., Đaković, N., & Mojzeš, A. (2020) · Molecules · doi:10.3390/molecules25225240 · Cited by 13
Zhang, Z., Fang, E., Rong, Y., Han, H., Gong, Q., Xiao, Y., Li, H., Mei, P., Li, H., Zhu, Z., et al. (2021) · PubMed Central · Cited by 13
RetractedHashimoto, M., Uesugi, N., Sugai, M., Ito, K., Yanagawa, N., Otsuka, K., Kajiwara, Y., Ueno, H., Sasaki, A., & Sugai, T. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03266-4 · Cited by 13
A protein with broad functions: damage-specific DNA-binding protein 2
Bao, N., Han, J., & Zhou, H. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07963-4 · Cited by 13
Wilson, R. B. (2017) · Europe PMC (PubMed Central) · doi:10.1515/pp-pp-2017-0001 · Cited by 12
Inhibition of hypoxia‐inducible factors suppresses subretinal fibrosis
Shoda, C., Lee, D., Miwa, Y., Yamagami, S., Nakashizuka, H., Nimura, K., Okamoto, K., Kawagishi, H., Negishi, K., & Kurihara, T. (2024) · The FASEB Journal · doi:10.1096/fj.202400540rrr · Cited by 13
Mechanism and regulation of epithelial–mesenchymal transition in cancer
Reed, I. K. G. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s73822 · Cited by 13
Chen, W., Chen, L., Cai, Z., Liang, D., Zhao, B., Zeng, Y., Liu, X., & Liu, J. (2016) · Tumor Biology · doi:10.1007/s13277-016-4823-6 · Cited by 12
The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia
Singh, V. K., Singh, R., Kushwaha, R., Verma, S. P., Tripathi, A. K., & Mahdi, A. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.912942 · Cited by 11
Everest‐Dass, A., Nersisyan, S. A., Maar, H., Novosad, V., Schröder‐Schwarz, J., Freytag, V., Stuke, J. L., Beine, M. C., Schiecke, A., Haider, M., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13535 · Cited by 11
Aquino, A., & Franzese, O. (2025) · Cancers · doi:10.3390/cancers17091547 · Cited by 13
Wu, X., Fang, J. C., Wang, Z., Chen, C., Liu, J., Wu, G., Yao, X., Liu, F., & Zhou, X. (2017) · PubMed Central · Cited by 11
microRNA-569 inhibits tumor metastasis in pancreatic cancer by directly targeting NUSAP1
Guo, X., Li, Y., Che, X., Hou, K., Qu, X., & Li, C. (2022) · Aging · doi:10.18632/aging.204035 · Cited by 11
Neddylation blockade induces HIF-1α driven cancer cell migration via upregulation of ZEB1
Park, J. B., Seo, J., Park, J., & Chun, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-75286-0 · Cited by 11
Bahadory, S., Sadraei, J., Zibaei, M., Pirestani, M., & Dalimi, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878724 · Cited by 10
Signal flow control of complex signaling networks
Lee, D., & Cho, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-50790-0 · Cited by 10
Zhang, H., Zhang, C. F., & Chen, R. (2017) · Europe PMC (PubMed Central) · Cited by 10
Rapanotti, M. C., Cugini, E., Scioli, M. G., Cenci, T., Anzillotti, S., Puzzuoli, M., Terrinoni, A., Ferlosio, A., Luca, A. D., & Orlandi, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083617 · Cited by 9
Is cancer an intelligent species?
Nicolazzo, C., Francescangeli, F., Magri, V., Giuliani, A., Zeuner, A., & Gazzaniga, P. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10123-0 · Cited by 10
DeFrates, K. G., Tong, E. C., Cheng, J., Heber‐Katz, E., & Messersmith, P. B. (2024) · Advanced Science · doi:10.1002/advs.202304716 · Cited by 11
Turano, M., Vicidomini, R., Cammarota, F., D’Agostino, V., Duraturo, F., Izzo, P., & Rosa, M. D. (2023) · Biomedicines · doi:10.3390/biomedicines11051428 · Cited by 9
The Role of Zinc Finger Proteins in Various Oral Conditions
Agnihotri, R., & Gaur, S. (2022) · The Scientific World JOURNAL · doi:10.1155/2022/4612054 · Cited by 8
Altıparmak, E. A., Eroğlu, G. Ö., Özdemir, N., Kuruca, S. E., & Bal‐Demirci, T. (2024) · Dalton Transactions · doi:10.1039/d4dt02774d · Cited by 7
Metadata
- Authors
- Zhang, W., Shi, X., Peng, Y., Wu, M., Zhang, P., Xie, R., Wu, Y., Yan, Q., Liu, S., & Wang, J.
- Affiliations
- Kunming University of Science and Technology (CN)
- Nanfang Hospital (CN)
- Corresponding author
- Liu, Side
- Wang, Jide
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-09
- Volume
- 10
- Issue
- 6
- Pages
- e0129603
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4461314
- OpenAlex
- W621464006
- Cited by
- 261
- References
- 33
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 14 · 2023: 25 · 2022: 28 · 2021: 28 · 2020: 35 · 2019: 24 · 2018: 34 · 2017: 26 · 2016: 18 · 2015: 5
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Southern Medical University
- Nanfang Hospital (G201227)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- HIF-1α, ZEB1, epithelial-mesenchymal transition, colorectal cancer, metastasis, hypoxia response element, transcriptional regulation, cell invasion, cell migration, vimentin, E-cadherin, deferoxamine, tumor suppressor
- MeSH terms
- Zinc Finger E-box-Binding Homeobox 1, Animals, Base Sequence, Humans, Liver Neoplasms, Mice, Nude, Molecular Sequence Data, Transcription Factors, Vimentin, Colorectal Neoplasms, Cadherins, Gene Expression Regulation, Neoplastic, Homeodomain Proteins, HT29 Cells, Response Elements, HCT116 Cells, Hypoxia-Inducible Factor 1, alpha Subunit, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
